Mozec Rx PTCA Balloon Dilatation Catheter, Mozec NC Rx PTCA Balloon Dilatation Catheter— 510(k) K181023

Name: FDA 510(k) clearance K181023
Creator: U.S. Food and Drug Administration
Published: 2018-05-17

Substantially Equivalent

Meril Life Sciences Private Limited

FDA 510(k) clearance K181023 for Mozec Rx PTCA Balloon Dilatation Catheter, Mozec NC Rx PTCA Balloon Dilatation Catheter, Substantially Equivalent on 2018-05-17. Applicant: Meril Life Sciences Private Limited. Device class: 2.

Clearance details

Applicant: Meril Life Sciences Private Limited
Product code: Code LOX
Device class: Class 2
Regulation: 21 CFR 870.5100
Advisory panel: Cardiovascular
Date received: 2018-04-17
Decision date: 2018-05-17
Decision: Substantially Equivalent
Clearance type: Special
Location: Vapi, IN

Download summary PDF View on FDA.gov ↗

Recent devices under product code LOX

view all

K261428 — NC Euphora Rapid Exchange Balloon Dilatation Catheter2026-08-14
K261759 — Euphora Rapid Exchange (RX) Balloon Dilatation Catheter2026-07-27
K252116 — Firefighter Pro PTCA Balloon Catheter2026-04-07
K254022 — FLASH Flex Aorto-Ostial Angioplasty System2026-04-02
K252295 — Ryurei2026-03-27

More clearances from Meril Life Sciences Private Limited

view all

K190619 — Aspiron(TM) Aspiration Catheter2019-04-29
K160961 — Mozec NC-Rx PTCA Baloon Dilatation Catheter2016-07-30
K131169 — MOZEC - RX PTCA BALLOON DILATATION CATHETER2013-12-24

Adverse events under product code LOX

product code LOX

Death: 190
Injury: 1,498
Malfunction: 9,670
Total: 11,358

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.